Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor of Clinical Outcome
1 other identifier
observational
81
1 country
1
Brief Summary
The aim of this study is to find the overall incidence of thrombotic microangiopathy in snakebite victims. As we know snakebite is a common in tropical regions. Many a times the early diagnosis of TMA is missed and precious time which could have helped in improving the patient prognosis is lost. Also via this study we wish to learn the role of cost effective test like peripheral smear which could help learn morphological picture of red blood cells and thus help in early prediction of patients clinical prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 28, 2021
CompletedFirst Submitted
Initial submission to the registry
April 10, 2021
CompletedFirst Posted
Study publicly available on registry
April 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedJune 14, 2021
June 1, 2021
1.4 years
April 10, 2021
June 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To find the number of peripheral smear samples of TMA snakebite in which schistocyte grading helps in predicting the patient clinical outcome
To find the number of PBS smears in which morphological evaluation of RBC in PBS examination helps in predicting clinical outcome in snakebite associated TMA
1 year
Secondary Outcomes (1)
To find the number of hematotoxic snakebites associated with thrombotic microangiopathy (TMA) cases within 7days of admission
1 year
Eligibility Criteria
All snakebite victims who meet the inclusion criteria would be included in the study
You may qualify if:
- All patients with a history of snakebite and with prolonged WBCT.
You may not qualify if:
- Patients administered with blood or blood components prior to admission
- Known case of bleeding disorders
- Known case of haemolytic anaemia
- Patients on antiplatelets or anticoagulants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jubilee Mission Medical College
Thrissur, Kerala, 680005, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Aboobacker Rafi, MD
Jubilee Mission Medical College and Research Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Junior Resident
Study Record Dates
First Submitted
April 10, 2021
First Posted
April 14, 2021
Study Start
January 28, 2021
Primary Completion
June 30, 2022
Study Completion
January 1, 2023
Last Updated
June 14, 2021
Record last verified: 2021-06